On January 6, 2020, the "International Symposium on the latest technology exchange of interventional therapy for cerebrovascular diseases" was held in Beijing, jointly sponsored by the professional committee of cerebrovascular diseases of China Research Hospital Association and the international medical center of Stanford University Hospital in the United States and co sponsored by Shanghai Dowell group. Chen cunwu, chairman of Shanghai Dowell group, and Dai Jingchun, general manager of Shanghai weizaozhitong Medical Technology Co., Ltd., attended the seminar.
Professor Wu Zhongxue, deputy director of Beijing Institute of neurosurgery and chairman of China cerebrovascular disease expert committee, served as the chairman of the meeting. More than 20 experts and professors in the field of cerebral nerve from major famous hospitals at home and abroad, including Beijing Tiantan Hospital, Shanghai Huashan Hospital and Stanford University Hospital, were invited to attend the seminar, Dr. John Lippert, founder and chief engineer of American Scientia vascular company, elaborated on the development process of nerve intervention technology and products and the technical characteristics and advantages of the latest products, focusing on the new features and functions of the second generation micro guide wire and micro catheter products. SV's products were unanimously affirmed and highly praised by experts.
